A coronavirus vaccine being developed at the University of Oxford is safe and induces an immune response to the disease. Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of the phase one clinical trial for the vaccine being developed by AstraZeneca and scientists at the University of Oxford.
Oxford Uni vaccine triggers COVID-19 immune response
